In this model, fingolimod increased the expression of the trophic factor vascular endothelial growth factor α (VEGFα) but not of brain-derived neurotrophic factor (BDNF), which has been shown to increase secondary to fingolimod treatment in other models of neurodegenerative diseases. This evidence concerns the gene VEGFA and neurodegenerative disease.